Shevanthi Nayagam
Overview
Explore the profile of Shevanthi Nayagam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1748
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sow A, Lemoine M, Toure P, Diop M, Lo G, De Veiga J, et al.
JHEP Rep
. 2022 Sep;
4(10):100533.
PMID: 36052221
Background & Aims: Strategies to implement HBV screening and treatment are critical to achieve HBV elimination but have been inadequately evaluated in sub-Saharan Africa (sSA). Methods: We assessed the feasibility...
12.
13.
Echeverria-Londono S, Li X, Toor J, de Villiers M, Nayagam S, Hallett T, et al.
BMC Public Health
. 2021 Nov;
21(1):2049.
PMID: 34753437
Background: Deaths due to vaccine preventable diseases cause a notable proportion of mortality worldwide. To quantify the importance of vaccination, it is necessary to estimate the burden averted through vaccination....
14.
de Villiers M, Nayagam S, Hallett T
Nat Commun
. 2021 Oct;
12(1):6223.
PMID: 34711822
In 2016 the World Health Organization set the goal of eliminating hepatitis B globally by 2030. Horizontal transmission has been greatly reduced in most countries by scaling up coverage of...
15.
Mohamed Z, Scott N, Nayagam S, Rwegasha J, Mbwambo J, Thursz M, et al.
Int J Drug Policy
. 2021 Oct;
99:103458.
PMID: 34624732
Background: Compared to other countries in sub-Saharan Africa, Tanzania has a relatively progressive illicit drug harm reduction (HR) policy, through a predominantly opioid substitution therapy-based programme. However, access to hepatitis...
16.
Vollmer M, Radhakrishnan S, Kont M, Flaxman S, Bhatt S, Costelloe C, et al.
BMC Health Serv Res
. 2021 Sep;
21(1):1008.
PMID: 34556119
Background: Hospitals in England have undergone considerable change to address the surge in demand imposed by the COVID-19 pandemic. The impact of this on emergency department (ED) attendances is unknown,...
17.
Whittaker C, Watson O, Alvarez-Moreno C, Angkasekwinai N, Boonyasiri A, Carlos Triana L, et al.
Clin Infect Dis
. 2021 Sep;
75(1):e224-e233.
PMID: 34549260
Background: The public health impact of the coronavirus disease 2019 (COVID-19) pandemic has motivated a rapid search for potential therapeutics, with some key successes. However, the potential impact of different...
18.
Toor J, Echeverria-Londono S, Li X, Abbas K, Carter E, Clapham H, et al.
Elife
. 2021 Jul;
10.
PMID: 34253291
Background: Vaccination is one of the most effective public health interventions. We investigate the impact of vaccination activities for type b, hepatitis B, human papillomavirus, Japanese encephalitis, measles, serogroup A,...
19.
Hui Z, Nayagam S, Chan P, Fuzhen W, Thursz M, Zundong Y, et al.
Bull World Health Organ
. 2021 Mar;
99(1):10-18.
PMID: 33658732
Objective: To determine the projected burden of hepatitis B virus (HBV) in China, the intervention strategies that can eliminate mother-to-child transmission (MTCT) by 2030 or earlier and the measurable parameters...
20.
Li X, Mukandavire C, Cucunuba Z, Echeverria Londono S, Abbas K, Clapham H, et al.
Lancet
. 2021 Jan;
397(10272):398-408.
PMID: 33516338
Background: The past two decades have seen expansion of childhood vaccination programmes in low-income and middle-income countries (LMICs). We quantify the health impact of these programmes by estimating the deaths...